secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001493152-25-013213
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals grants 500k shares and 2M options to CEO; CFO and directors each receive 100k shares
--------------------------------------------------------------------------------

- CEO Jacob Cohen receives 500,000 common shares as 2025 bonus and options to purchase 2,000,000 shares at $2.30.
- Options vest over 18 months (500k per milestone); full acceleration on change of control or termination without cause.
- CFO Eugene Johnston and directors Myers, Hamilton, D'Alessio each receive 100,000 fully vested common shares as 2025 bonuses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225013213/0001493152-25-013213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225013213/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer